Jeff Yass’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-62,400
| Closed | -$8.51M | – | 12072 |
|
|
2020
Q3 | $8.51M | Sell |
62,400
-23,000
| -27% | -$2.45M | ﹤0.01% | 2376 |
|
|
2020
Q2 | $8.25M | Sell |
85,400
-125,800
| -60% | -$10.5M | ﹤0.01% | 2367 |
|
|
2020
Q1 | $9.9M | Buy |
211,200
+160,500
| +317% | +$10.3M | ﹤0.01% | 1751 |
|
|
2019
Q4 | $3.69M | Sell |
50,700
-19,300
| -28% | -$1.17M | ﹤0.01% | 3396 |
|
|
2019
Q3 | $3.65M | Buy |
70,000
+14,000
| +25% | +$744K | ﹤0.01% | 3185 |
|
|
2019
Q2 | $2.81M | Sell |
56,000
-21,500
| -28% | -$1.05M | ﹤0.01% | 3551 |
|
|
2019
Q1 | $4.03M | Buy |
77,500
+36,000
| +87% | +$1.66M | ﹤0.01% | 2714 |
|
|
2018
Q4 | $2.03M | Buy |
41,500
+9,200
| +28% | +$506K | ﹤0.01% | 3499 |
|
|
2018
Q3 | $2.11M | Sell |
32,300
-14,700
| -31% | -$864K | ﹤0.01% | 3897 |
|
|
2018
Q2 | $2.33M | Sell |
47,000
-65,400
| -58% | -$3.17M | ﹤0.01% | 3757 |
|
|
2018
Q1 | $5.49M | Buy |
112,400
+97,300
| +644% | +$5.06M | ﹤0.01% | 2431 |
|
|
2017
Q4 | $636K | Buy |
+15,100
| New | +$582K | ﹤0.01% | 6157 |
|
Jeff Yass's MYOK Position: Q4 2020 in Review
Jeff Yass sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 20,088 shares — an estimated $2.74M sold.
Jeff Yass first reported a position in MYOK in Q4 2015 and held it in 10 quarters. The position peaked at $8.61M in Q2 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Jeff Yass reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Jeff Yass sold 20,088 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $2.74M.
- Jeff Yass first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 10 quarters.
- Jeff Yass's MyoKardia, Inc. Common Stock position peaked at $8.61M in Q2 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.